glutathione and parkinson's S-transferase: A keystone in disease pathogenesis therapy A simple antioxidant may help
Description
The following is a summary of documented tissue systems from peer-reviewed literature: This cross-tissue activity profile is directly attributable to the fact that its primary mechanisms VEGFR2-driven angiogenesis and NO system modulation are not tissue-specific
L.Rivera-KohrD
When it might be considered (conceptually): A patient has clear metabolic disease, is doing the basics well, and theres a specific reason to pursue an adjunct rather than optimizing the primary plan
Build your protocol using this framework
